Heart Disease Clinical Trials in Seattle

Showing 101-120 of 207 trials

Chronic Total Occlusion Percutaneous Coronary Intervention Study

NCT03988166

The objective of this study is to evaluate angiographic confirmation of placement of any guidewire beyond the CTO, in the true vessel lumen, in patients undergoing CTO percutaneous coronary intervention (PCI) in which at least one Teleflex guidewire and at least one Turnpike catheter are used.

Chronic Total OcclusionIschemic Heart DiseaseChronic Total Occlusion of Coronary Artery

Vascular Solutions LLC150 participantsStarted May 2020

Torrance, California, United States • Atlanta, Georgia, United States • Atlanta, Georgia, United States +10 more locations

COMPLETEDNA< 1 mile

Effect of Commute Traffic on Vascular Function

NCT05454930

The investigators will assess the vascular effects of riding in a car in heavily trafficked roadways, and whether filtering the car's air reduces those effects.

Cardiovascular Diseases

University of Washington16 participantsStarted Jan 2015

Seattle, Washington, United States

Chronic Total Occlusion Percutaneous Coronary Intervention Study

Effect of Commute Traffic on Vascular Function

Heart Disease Trials in Other Cities

SHIELD II Clinical Investigation

MOMENTUM 3 IDE Clinical Study Protocol

Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardiac Transplantation

Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device (LVAD) and Medical Management

Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction

Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion

St. Jude Medical Product Longevity and Performance (SCORE) Registry

Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia

The Product Surveillance Registry REVERSE Post Approval Study

Precision Event Monitoring for Patients With Heart Failure Using HeartLogic

A Study to Test the Effect of Empagliflozin in Patients Who Are in Hospital for Acute Heart Failure

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)

PAtient RegisTry Assessing Effectiveness and Safety of HEart Failure treatmeNt With LCZ696 acrOss CaNada

Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients With the Use of a VDD-ICD Lead

Comparison of Pre- and Post-discharge Initiation of LCZ696 Therapy in HFrEF Patients After an Acute Decompensation Event

Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)

COBRA PZF™ Coronary Stent for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term DAPT

Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads

Other Conditions in Seattle